Angelman Syndrome Research and Treatment

Logan Wink, MD, is the director of the Angelman Syndrome Research and Treatment Center. Her primary focus is behavioral management of individuals with Angelman Syndrome of all ages. Currently, Dr. Wink is working in collaboration with Boston Children’s Hospital on two studies, including a longitudinal, descriptive study.

Related Publications

Show All

Wink LK, Erickson CA, McDougle CJ, Stigler KA. Pharmacotherapy of autism spectrum disorders. In The Handbook of Autism: A Concise Guide, Treadwell-Deering D, Kober D (eds), World Scientific, Inc., New Jersey, 2012. 

Early MC, Erickson CA, Wink LK, McDougle CJ, Scott EL. Case Report: 16-Year-Old Male with Autistic Disorder with Preoccupation with Female Feet. J Autism Dev Disord. Jun;42(6):1133-7. 2012.

Erickson CA, Stigler KA, Wink LK, Mullett JE, Kohn A, Posey DJ, McDougle CJ. A prospective open-label trial of aripiprazole in fragile X syndrome. Psychopharmacology (Berl). Jul;216(1):85-90. 2011.

Erickson CA, Weng N, Weiler IJ, Greenough WT, Stigler KA, Wink LK, McDougle CJ. Open-label riluzole in fragile X syndrome. Brain Research. Mar 22;1380:264-70. 2011.

Wink LK, Erickson CA, Stigler, KA, McDougle CJ. Riluzole in autistic disorder. J Child Adolesc Psychopharmacology.  Aug;21(4):375-9. 2011.

Kowalski JL, Wink LK, Blankenship K, Habenicht CD, Erickson CA, Stigler KA, McDougle CJ. Paliperidone Palmitate in a Child with Autistic Disorder. J Child Adolesc Psychopharmacology. Oct;21(5):491-3. 2011.

Orsagh-Yentis DK, Wink LK, Erickson CA, Stigler KA, McDougle CJ. Buspirone for Bruxism in a Child with Pervasive Developmental Disorder-Not Otherwise Specified . J Child Adolesc Psychopharmacol. Dec;21(6):643-5. 2011.

Erickson CA, Early M, Stigler KA, Wink LK, Mullett JE, McDougle CJ. An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder . J Child Adolesc Psychopharmacol. Dec;21(6):565-9. 2011.

Wink LK, Plawecki MH, Erickson CA, Stigler KA, McDougle CJ. Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Expert Opin Emerg Drugs. Sep;15(3):481-94. 2010.

Wink LK, Erickson CA, McDougle CJ. Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders . Current Treat Options Neurology. Nov;12(6):529-38. 2010.

Additional Publications

For a complete and updated list of publications from the Erickson-Wink Lab please view this PubMed listing.

Contact Us

Logan Wink, MD

Mailing Address:
Division of Psychiatry
3430 Burnet Ave.
MLC 4002
Cincinnati, OH 45229

Phone: 513-803-3582